{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:36:00Z","timestamp":1789022160562,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s11739-024-03847-6","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T04:44:25Z","timestamp":1736138665000},"page":"691-700","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Use of nicotine products, prescription drug products, and other methods to stop smoking by US adults in the 2022 National Health Interview Survey"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4893-9178","authenticated-orcid":false,"given":"Floe","family":"Foxon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0856-3540","authenticated-orcid":false,"given":"Raymond","family":"Niaura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"issue":"9","key":"3847_CR1","doi-asserted-by":"publisher","first-page":"4876","DOI":"10.3390\/ijerph18094876","volume":"18","author":"DT Levy","year":"2021","unstructured":"Levy DT, S\u00e1nchez-Romero LM, Travis N, Yuan Z, Li Y, Skolnick S, Jeon J, Tam J, Meza R (2021) US nicotine vaping product SimSmoke simulation model: the effect of vaping and tobacco control policies on smoking prevalence and smoking-attributable deaths. Int J Environ Res Public Health 18(9):4876","journal-title":"Int J Environ Res Public Health"},{"issue":"10258","key":"3847_CR2","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"GBD 2019 Risk Factors Collaborators","year":"2020","unstructured":"GBD 2019 Risk Factors Collaborators (2020) Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396(10258):1223\u20131249","journal-title":"Lancet"},{"issue":"11","key":"3847_CR3","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3390\/ijerph14111403","volume":"14","author":"B Rodu","year":"2017","unstructured":"Rodu B, Plurphanswat N (2017) Quit methods used by American Smokers, 2013\u20132014. Int J Environ Res Public Health 14(11):1403","journal-title":"Int J Environ Res Public Health"},{"key":"3847_CR4","doi-asserted-by":"publisher","DOI":"10.5888\/pcd14.160600","author":"RS Caraballo","year":"2017","unstructured":"Caraballo RS, Shafer PR, Patel D, Davis KC, McAfee TA (2017) Quit methods used by US adult cigarette smokers, 2014\u20132016. Prev Chronic Dis. https:\/\/doi.org\/10.5888\/pcd14.160600","journal-title":"Prev Chronic Dis"},{"key":"3847_CR5","unstructured":"Premarket tobacco product marketing granted orders. https:\/\/www.fda.gov\/tobacco-products\/premarket-tobacco-product-applications\/premarket-tobacco-product-marketing-granted-orders.  Accessed on 27 Jan 2024"},{"key":"3847_CR6","doi-asserted-by":"publisher","DOI":"10.5888\/pcd17.200173","author":"K Walton","year":"2020","unstructured":"Walton K, Wang TW, Prutzman Y, Jamal A, Babb SD (2020) Characteristics and correlates of recent successful cessation among adult cigarette smokers, United States, 2018. Prev Chronic Dis. https:\/\/doi.org\/10.5888\/pcd17.200173","journal-title":"Prev Chronic Dis"},{"issue":"4","key":"3847_CR7","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2105\/AJPH.2022.307197","volume":"113","author":"B Zablotsky","year":"2023","unstructured":"Zablotsky B, Lessem SE, Gindi RM, Maitland AK, Dahlhamer JM, Blumberg SJ (2023) Overview of the 2019 National Health Interview Survey Questionnaire Redesign. Am J Public Health 113(4):408\u2013415","journal-title":"Am J Public Health"},{"key":"3847_CR8","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.15585\/mmwr.mm6946a4","volume":"69","author":"ME Cornelius","year":"2020","unstructured":"Cornelius ME (2020) Tobacco product use among adults\u2014United States, 2019. MMWR Morb Mortal Wkl Rep 69:1736\u20131742","journal-title":"MMWR Morb Mortal Wkl Rep"},{"key":"3847_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.15585\/mmwr.mm7111a1","volume":"71","author":"ME Cornelius","year":"2022","unstructured":"Cornelius ME (2022) Tobacco product use among adults\u2014United States, 2020. MMWR Morb Mortal Wkl Rep 71:397\u2013405","journal-title":"MMWR Morb Mortal Wkl Rep"},{"issue":"12","key":"3847_CR10","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJMp1707409","volume":"377","author":"S Gottlieb","year":"2017","unstructured":"Gottlieb S, Zeller M (2017) A nicotine-focused framework for public health. N Engl J Med 377(12):1111\u20131114","journal-title":"N Engl J Med"},{"key":"3847_CR11","unstructured":"About electronic cigarettes (e-cigarettes). https:\/\/web.archive.org\/web\/20240102195530\/https:\/\/www.cdc.gov\/tobacco\/basic_information\/e-cigarettes\/about-e-cigarettes.html. Accessed on 27 Jan 2024"},{"issue":"9","key":"3847_CR12","first-page":"015226","volume":"9","author":"N Lindson","year":"2023","unstructured":"Lindson N, Theodoulou A, Ord\u00f3\u00f1ez-Mena JM, Fanshawe TR, Sutton AJ, Livingstone-Banks J, Hajizadeh A, Zhu S, Aveyard P, Freeman SC et al (2023) Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses. Cochrane Database Syst Rev 9(9):015226","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"3847_CR13","first-page":"592","volume":"20","author":"BT Suehs","year":"2014","unstructured":"Suehs BT, Davis C, Galaznik A, Joshi AV, Zou KH, Patel NC (2014) Association of out-of-pocket pharmacy costs with adherence to varenicline. J Manag Care Pharm 20(6):592\u2013600","journal-title":"J Manag Care Pharm"},{"issue":"5","key":"3847_CR14","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1586\/14737167.2013.837770","volume":"13","author":"A Galaznik","year":"2013","unstructured":"Galaznik A, Cappell K, Montejano L, Makinson G, Zou KH, Lenhart G (2013) Impact of access restrictions on varenicline utilization. Expert Rev Pharmacoecon Outcomes Res 13(5):651\u2013656","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"3847_CR15","unstructured":"US Centers for Disease Control and Prevention, US Department of Health and Human Services, Division of Health Interview Statistics, National Center for Health Statistics: National Health Interview Survey 2022 survey description (2023)"},{"issue":"12","key":"3847_CR16","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/ntr\/nts002","volume":"14","author":"R Borland","year":"2012","unstructured":"Borland R, Partos TR, Cummings KM (2012) Systematic biases in cross-sectional community studies may underestimate the effectiveness of stop-smoking medications. Nicotine Tob Res 14(12):1483\u20131487","journal-title":"Nicotine Tob Res"},{"key":"3847_CR17","doi-asserted-by":"crossref","unstructured":"Parker JD, Talih M, Irimata KE, Zhang G, Branum AM, Davis D: National Center for Health Statistics data presentation standards for rates and counts. Vital Health Stat 2023, 2(200)","DOI":"10.15620\/cdc:124368"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-024-03847-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-024-03847-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-024-03847-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T01:04:50Z","timestamp":1745024690000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-024-03847-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["3847"],"URL":"https:\/\/doi.org\/10.1007\/s11739-024-03847-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.07.11.24310141","asserted-by":"object"}]},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"assertion":[{"value":"1 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare the following potential conflicts of interests: F.F. provides consulting services through Pinney Associates on tobacco harm reduction to Juul Labs Inc., which had no involvement in this article. As of October 2024, Pinney Associates also consults to Philip Morris International solely on US regulatory pathways for non-combustible, non-tobacco, nicotine products, which also had no involvement in this article. Pinney Associates does not consult on combustible tobacco products. R.N. has received grant and contractual funding from the National Institutes of Health and the Food and Drug Administration; served as a paid consultant to the Government of Canada via a contract with Industrial Economics Inc; received an honorarium for a virtual meeting from Pfizer Inc.; received other NIDA grants paid to his employers; received salary from the Steven Schroeder Institute for Tobacco Research and Policy Studies at The Legacy Foundation, now Truth Initiative, New York University School of Global Public Health; and communicated with Juul Labs personnel, for which there was no compensation, and received hospitality in the form of meals at some meetings; none of which supported the work reported here. The Progressive Policy Institute sponsored a trip (travel and lodging) for R.N. to present a paper at a symposium: can e-cigarettes help tobacco cigarette smokers quit? A review of the evidence, Tobacco Harm Reduction\u2014an Update, 54th annual meeting of the Japanese Society of Neuropsychopharmacology, jointly held with the 34th annual meeting of the Japanese Society of Clinical Neuropsychopharmacology and the 35th World Congress Collegium International Neuro-Psychopharmacologicum, Tokyo International Forum, Tokyo, Japan, May 24, 2024; no honorarium, consulting fee or other payment was provided.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Only publicly available, de-identified survey data were used; therefore, this study is exempt from NIH human subjects research under NIH exemption 4 and did not require institutional review board review. These analyses were exploratory and were not preregistered.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Statements"}},{"value":"This study uses only secondary, de-identified data from CDC\u2019s National Health Interview Survey (NHIS), which are publicly available. NHIS data were collected by CDC\u2019s National Center for Health Statistics (NCHS) in compliance with ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights statement"}},{"value":"It was obtained from all participants by NCHS. No additional ethical approval or informed consent was required by the authors of this study for analysis of the NHIS data; this study is exempt from NIH human subjects research under NIH exemption 4.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}